As part of Robert Gallo's NCI team, Wong-Staal helped discover HTLV-1 in 1979, the first human retrovirus ever identified, later linked to adult T-cell leukemia.
In 1979, working in Robert Gallo's laboratory at the U.S. National Cancer Institute, Flossie Wong-Staal was part of the team that discovered HTLV-1 (Human T-lymphotropic virus type 1), the first retrovirus ever shown to infect humans and cause disease. This discovery overturned the prevailing skepticism in the scientific community about whether retroviruses could cause human illness at all.
HTLV-1 was subsequently linked to adult T-cell leukemia/lymphoma, a rare and aggressive blood cancer, providing the first definitive molecular evidence that a retrovirus could cause cancer in humans. Wong-Staal's contributions to characterizing the virus's genome and replication mechanisms were critical to establishing this causal link.
This discovery was foundational not only for cancer virology but for the emerging field of human retrovirology as a whole. It provided the conceptual and technical groundwork that would prove indispensable just a few years later, when a new and devastating epidemic — AIDS — emerged, and scientists needed to identify its viral cause. Wong-Staal's expertise in retrovirus molecular biology, honed through the HTLV-1 work, positioned her to become one of the leading figures in the subsequent race to characterize HIV.
While the exact calendar date of the discovery announcement is not preserved in accessible historical records, the year 1979 marks a watershed moment in virology, and Wong-Staal's role in it is well documented by NIH history archives and academic biographies.